A multistate model of the genetic risk of Alzheimer's disease

Experimental Aging Research

Volumn 28, Issue 4, 2002, Pages 477-499

  Ewbank, Douglas C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; INCIDENCE; MODEL; POPULATION GENETICS; PREVALENCE; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; HUMANS; INCIDENCE; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; MODELS, GENETIC; MODELS, STATISTICAL; PREVALENCE; RISK FACTORS;

EID: 0036792418     PISSN: 0361073X     EISSN: None     Source Type: Journal    
DOI: 10.1080/03610730290103096     Document Type: Article

References (61)

1. Barclay, L. L., Zemcov, A., Blass, J. P., & McDowell, F. H. (1985). Factors associated with duration of survival in Alzheimer's disease. Biological Psychiatry, 20, 86-93.
2. Berg, L., Miller, J. P., Baty, J., Rubin, E. H., Morris, J. C., & Figiel, G. (1992). Mild senile dementia of the Alzheimer type 4. Evaluation of intervention. Annals of Neurology, 31, 242-249.
3. Bickeböller, H., Campion, D., Brice, A., Amouyel, P., Hannequin, D., Didierjean, O., Penet, C., Martin, C., Pérez-Tur, J., Michon, A., Dubois, B., Ledoze, F., Thomas-Anterion, C., Pasquier, F., Puel, M., Demonet, J.-F., Moreaud, O., Babron, M.-C., Meulien, D., Guez, D., Chartier-Harlin, M.-C., Frebourg, T., Agid, Y., Martinez, M., & Clerget-Darpoux, F. (1997). Apolipoprotein E and Alzheimer disease: Genotype-specific risks by age and sex. American Journal of Human Genetics, 60, 439-446.
4. Bird, T. D., Levy-Lahad, E., Poorkaj, P., Sharma, V., Nemens, E., Lahad, A., Lampe, T. H., & Schellenberg, G. D. (1996). Wide range in age of onset for chromosome 1-related familial Alzheimer's disease. Annals of Neurology, 40, 932-936.
5. Blacker, D., Haines, J. L., Rodes, L., Terwedow, H., Harrell, L. E., Perry, R. T., Bassett, S. S., Chase, G., Meyers, D., Albert, M. S., & Tanzi, R. (1997). ApoE-4 and age at onset of Alzheimer's disease: The NIMH Genetics Initiative. Neurology, 48, 139-147.
6. Breitner, J. C. S., Jarvik, G. P., Plassman, B. L., Saunders, A. M., & Welsh, K. A. (1998). Risk of Alzheimer disease with the, ε4 allele for apolipoproteine in a population-based study of men aged 62-73 years. Alzheimer Disease and Associated Disorders, 12, 40-44.
7. Canadian Study of Health and Aging Working Group (1994). Canadian Study of Health and Aging: Study methods and prevalence of dementia. Canadian Medical Association Journal, 150, 899-913.
8. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C. J., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., Tanzi, R. E., Gusella, J. F., Small, G. W., Roses, A. D., Pericak-Vance, M. A., & Haines, J. L. (1995). Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology, 45, 1323-1328.
9. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
10. Cruts, M., & Van Broeckhoven, C. (1998). Molecular genetics of Alzheimer's disease. In J. H. Growdon & M. N. Rossor (Eds.), The Dementias (pp. 155-170). Boston: Butterworth-Heinemann.
11. Cruts, M., van Duijn, C. M., Backhovens, H., Van den Broeck, M., Wehnert, A., Serneels, S., Sherrington, R., Hutton, M., Hardy, J., St George-Hyslop, P. H., Hofman, A., & Van Broeckhoven, C. (1998). Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Human Molecular Genetics, 7, 43-51.
12. Ebly, E. M., Hogan, D. B., & Parhad, I. M. (1995). Cognitive impairment in the nondemented elderly. Archives of Neurology, 52, 612-619.
13. Ebly, E. M., Parhad, I. M., Hogan, D. B., & Fung, T. S. (1994). Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology, 44, 1593-1600.
14. Eggertsen, G., Tegelman, R., Ericsson, S., Angelin, B., & Berglund, L. (1993). Apolipoprotein E polymorphism in a healthy Swedish population: Variation of alleles frequency with age and relation to serum lipid concentrations. Clinical Chemistry, 39, 2125-2129.
15. Eichner, J. E., Kuller, L. H., Ferrell, R. E., Meilahn, E. N., & Kamboh, M. I. (1990). Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the Healthy Women Study. Arteriosclerosis, 10, 379-385.
16. Evans, D. A., Funkenstein, H. H., Albert, M. S., Scherr, P. A., Crook, N. R., Chown, M. J., Hebert, L. E., Hennekens, C. H., & Taylor, J. O. (1989). Prevalence of Alzheimer's disease in a community population of older persons. Journal of the American Medical Association, 262, 2551-2556.
17. Ewbank, D. C. (1998). Effects of age and ethnicity on the link between APOE, ε4 and Alzheimer disease. Journal of the American Medical Association, 279, 580-581.
18. Ewbank, D. C. (1999). Deaths attributable to Alzheimer's disease in the U.S. American Journal of Public Health, 89, 90-92.
19. Ewbank, D. C. (2002). Mortality differences by APOE genotype estimated from demographic synthesis. Genetic Epidemiology, 22, 146-155.
20. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., Myers, R. H., Pericak-Vance, M. A., Risch, N., van Duijn, C. M., & APOE and Alzheimier Disease Meta Analysis Consortium (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. Journal of the American Medical Association, 278, 1349-1356.
21. Gerdes, L. U., Klausen, I. C., Sihm, I., & Færgeman, O. (1992). Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genetic Epidemiology, 9, 155-167.
22. Gómez-Isla, T., Rebeck, G. W., Irizarry, M. C., Greenberg, S. M., & Hyman, B. T. (1998) Apolipoprotein E and Alzheimer's disease. In J. H. Growdon & M. N. Rossor (Eds.), The Dementias (pp. 171-188). Boston, Butterworth-Heinemann. Blue Books of Practical Neurology.
23. Habbema, J. D. F., & Dippel, D. W. J. (1986). Survivors-only bias in estimating survival in Alzheimer's disease and vascular dementias. Neurology, 36, 1009.
24. Hebert, L. E., Scherr, P. A., Beckett, L. A., Albert, M. S., Pilgrim, D. M., Chown, M. J., Funkenstein, H. H., & Evans, D. A. (1995). Age-specific incidence of Alzheimer's disease in a community population. Journal of the American Medical Association, 273, 1354-1359.
25. Henderson, A. S., Easteal, S., Jorm, A. F., Mackinnon, A. J., Korten, A. E., Christensen, H., Croft, L., & Jacomb, P. A. (1995). Apolipoprotein E allele, four, dementia, and cognitive decline in a population sample. Lancet, 346, 1387-1390.
26. Hixson, J. E. (1991). Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. Arteriosclerosis and Thrombosis, 11, 1237-1244.
27. Houlden, H., Crook, R., Backhovens, H., Prihar, G., Baker, M., Hutton, M., Rossor, M., Martin, J. J., Van Broeckhoven, C., & Hardy, J. (1998). Apoe genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families. American Journal of Medical Genetics, 81, 117-121.
28. Ibarreta, D., Gómez-Isla, T., Portera-Sánchez, A., Parrilla, R., & Ayuso, M. S. (1995). Apolipoprotein E genotype in Spanish patients of Alzheimer's or Parkinson's disease. Journal of the Neurological Sciences, 134, 146-149.
29. Jorm, A. F., Korten, A. E., & Henderson, A. S. (1987). The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatrica Scandinavica, 76, 465-479.
30. Kukull, W. A., Schellenberg, G. D., Bowen, J. D., Mccormick, W. C., Yu, C.-E., Teri, L., Thompson, J. D., O'Meara, E. S., & Larson, E. B. (1996). Apolipoprotein E in Alzheimer's disease risk and case detection: A case-control study. Journal of Clinical Epidemiology, 49, 1143-1148.
31. Letenneur, L., Commenges, D., Dartigues, J. F., & Barberger-Gateau, P. (1994). Incidence of dementia and Alzheimer's disease in elderly community residents of South-Western France. International Journal of Epidemiology, 23, 1256-1261.
32. Levy-Lahad, E., & Bird, T. D. (1996). Genetic factors in Alzheimer's disease: A review of recent advances. Annals of Neurology, 40, 829-840.
33. Lobo, A., Dewey, M., Copeland, J., Día, J.-L., & Saz, P. (1992). The prevalence of dementia among elderly people living in Zaragoza and Liverpool. Psychological Medicine, 22, 239-243.
34. Manton, K.G., Stallard, E., & Vaupel, J. W. (1986). Alternative models for the heterogeneity of mortality risks among the aged. JASA, 81, 635-644.
35. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-943.
36. Mölsä, P. K., Marttila, R. J., & Rinne, U. K. (1995). Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia. Acta Neurologica Scandinavica, 91, 159-164.
37. Myers, R. H., Schaefer, E. J., Wlson, P. W. F., D'Agostino, R., Ordovas, J. M., Espino, A., Au, R., White, R. F., Knoefel, J. E., Cobb, J. L., McNulty, K. A., Beiser, A., & Wolf, P. A. (1996). Apolipoprotein E ε4 association with dementia in a population-based study: The Framingham Study. Neurology, 46, 673-677.
38. National Center for Health Statistics.U.S. Decennial Life Tables for 1989-1991. Hyattsville, MD: Government Printing Office.
39. Nielsen, H., Lolk, A., Pedersen, I., Autzen, M., Sennef, C., & Kragh-Sorensen, P. (1991). The accuracy of early diagnosis and predictors of death in Alzheimer's disease and vascular dementia-a follow-up study. Acta Psychiatrica Scandinavica, 84, 277-282.
40. Olichney, J. M., Hofstetter, C. R., Galasko, D., Thai, L. J., & Katzman, R. (1995). Death certificate reporting of dementia and mortality in an Alzheimer's Disease Research Center cohort. Journal of the American Geriatrics Society, 43, 890-893.
41. Ordovas, J. M., Litwack-Klein, L., Wilson, P. W. F., Schaefer, M. M., & Schaefer, E. J. (1987). Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE and apoE isoforms. Journal of Lipid Research, 28, 371-380.
42. Prencipe, M., Casini, A. R., Ferretti, C., Lattanzio, M. T., Fiorelli, M., & Culasso, F. (1996). Prevalence of dementia in an elderly rural population: Effects of age, sex, and education. Journal of Neurology, Neurosurgery and psychiatry, 60, 628-633.
43. Preston, G. A. N. (1986). Dementia in elderly adults: Prevalence and Institutionalization. Journal of Gerontology, 41, 261-267.
44. Raiford, K., Anton-Johnson, S., Haycox, Z., Nolan, K., Schaffer, A., Caimano, C., Fillenbaum, G., & Heyman, A. (1994). CERAD Part VII: Accuracy of reporting dementia on death certificates of patients with Alzheimer's disease. Neurology, 44, 2208-2209.
45. Rebeck, G. W., Perls, T. T., West, H. L., Sodhi, P., Lipsitz, L. A., & Hyman, B. T. (1994). Reduced apolipoprotein ε4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology, 44, 1513-1516.
46. Ritchie, K. (1998). Is Alzheimer's disease just old age? In J. H. Growdon & M. N. Rossor (Eds.), The Dementias (pp. 403-414). Boston, Butterworth-Heinemann. Blue Books of Practical Neurology.
47. Ritchie, K., & Kildea, D. (1995). Is senile dementia 'Age-related' or 'ageing-related'?-Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet, 346, 931-934.
48. Ritchie, K., Kildea, D., & Robine, J.-M. (1992). The relationship between age and the prevalence of senile dementia: A meta-analysis of recent data. International Journal of Epidemiology, 21, 763-769.
49. Rocca, W. A., Hofman, A., Brayne, C., Breteler, M. M., Clarke, M., Copeland, J. R. M., Dartigues, J.-F., Engedal, K., Hagnell, O., Heeren, T. J., Jonker, C., Lindesay, J., Lobo, A., Mann, A. H., Mölsä, P. K., Morgan, K., O'Connor, D. W., da Silva Droux, A., Sulkava, R. K. D. W. K., & Amaducci, L. (1991). Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Annals of Neurology, 30, 381-390.
50. Selvin, S. (1991). Statistical analysis of epidemiologic data. New York: Oxford University Press.
51. Skoog, I., Nilsson, L., Pahnertz, B., Andreasson, L.-A., & Svanborg, A. (1993). A population-based study of dementia in 85-year-olds. New England Journal of Medicine, 328, 153-158.
52. Sobel, E., Louhija, J., Sulkava, R., Davanipour, Z., Kontula, K., Miettinen, H., Tikkanen, M., Kainulainen, K., & Tilvis, R. (1995). Lack of association of apolipoprotein E allele, four with late-onset Alzheimer's disease among Finnish centenarians. Neurology, 45, 903-907.
53. St Clair, D., Rennie, M., Slorach, E., Norrman, J., Yates, C., & Carothers, A. (1995). Apolipoprotein E ε4 allele is a risk factor for familial and sporadic presenile Azheimer's disease in both homozygote and heterozygote carriers. Journal of Medical Genetics, 32, 642-644.
54. Tanzi, R. E., Kovacs, D. M., Kim, R.-W., Moir, R. D., Guenette, S. Y., & Wasco, W. (1996). The presenilin genes and their role in early-onset familial Alzheimer's disease. Alzheimer's Disease Review, 1, 90-98.
55. van Duijn, C., de Knijff, P., Wehnert, A., De Voecht, J., Bronzova, J. B., Havekes, L. M., Hofman, A., & Van Broeckhoven, C. (1995). The apolipoprotein E, two allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Annals of Neurology, 37, 605-610.
56. van Duijn, C. M., Stijnen, T., & Hofman, A. (1991). Risk factors for Alzheimer's disease: Overview of the EURODEM collaborative re-analysis of case-control studies. International Journal of Epidemiology, 20, S4-S11.
57. von Strauss, E., Viitanen, M., De Ronchi, D., Winblad, B., & Fratiglioni, L. (1999). Aging and the occurrence of dementia: Findings from a population-based cohort with a large sample of nonagenarians. Archives of Neurology, 56, 587-592.
58. Walsh, J. S., Welch, H. G., & Larson, E. B. (1990). Survival of outpatients with Alzheimer-type dementia. Annals of Internal Medicine, 113, 429-434.
59. Warwick Daw, E., Payami, H., Nemens, E. J., Nochlin, D., Bird, T. D., Schellenberg, G. D., & Wijsman, E. M. (2000). The number of trait loci in late-onset Alzheimer disease. American Journal of Human Genetics, 66, 196-204.
60. Yashin, A. I., De Benedictis, G., Vaupel, J. W., Tan, Q., Andreev, K. F., Iachine, I. A., Bonafe, M., DeLuca, M., Valensin, S., Carotenuto, L., & Franceschi, C. (1999). Genes, demography and life span: The contribution of demographic data in genetic studies of aging and longevity. American Journal of Human Genetics, 65, 1178-1193.
61. Yashin, A. I., De Benedictis, G., Vaupel, J. W., Tan, Q., Andreev, K. F., Iachine, I. A., Bonafe, M., Valensin, S., De Luca, M., Carotenuto, L., & Franceschi, C. (2000). Genes and longevity: Lessons from studies of centenarians. Journal of Gerontology, 55A, B319-B328.